Skip to main content
. 2021 Mar 14;13(3):475. doi: 10.3390/v13030475

Table 1.

Sociodemographic characteristics and comorbidities of the non-hepatitis C virus (HCV), HCV-untreated, and HCV-treated cohorts.

Parameters Non-HCV
(n = 16,880)
HCV-Untreated
(n = 3376)
HCV-Treated
(n = 1688)
p Value
Age, years 51.5 (12.0) 51.6 (12.0) 51.4 (11.9) 0.88
Male sex, n (%) 9130 (54.1) 1826 (54.1) 913 (54.1) >0.99
Occupation <0.0001
White-collar 9545 (56.6) 1439 (42.6) 709 (42.0)
Blue-collar 6060 (35.9) 1646 (48.8) 873 (51.7)
Other 1275 (7.55) 291 (8.62) 106 (6.28)
Urbanisation <0.0001
Urban 5379 (31.9) 753 (22.3) 362 (21.5)
Suburban 8074 (47.8) 1572 (46.6) 794 (47.0)
Rural 3427 (20.3) 1051 (31.1) 532 (31.5)
Geographic region <0.0001
Northern 8015 (47.5) 1011 (30.0) 466 (27.6)
Central 3286 (19.5) 735 (21.8) 366 (21.7)
Southern 4782 (28.3) 1429 (42.3) 764 (45.3)
Eastern and outlying islands 797 (4.72) 201 (5.95) 92 (5.45)
Monthly Income (NT$) <0.0001
<15,840 5845 (34.6) 1008 (29.9) 437 (25.9)
15,840–24,999 6431 (38.1) 1689 (50.0) 884 (52.4)
≥25,000 4604 (27.3) 679 (20.1) 367 (21.7)
Comorbidities
Myocardial infarction 2092 (12.4) 780 (23.1) 313 (18.5) <0.0001
Cerebrovascular disease 1182 (7.00) 454 (13.5) 184 (10.9) <0.0001
Chronic pulmonary disease 4025 (23.8) 1204 (35.7) 623 (36.9) <0.0001
Diabetes mellitus 2328 (13.8) 960 (28.4) 475 (28.1) <0.0001
Renal disease 489 (2.90) 348 (10.3) 96 (5.69) <0.0001
Hypertension 4830 (28.6) 1503 (44.5) 745 (44.1) <0.0001
Hyperlipidaemia 1916 (11.4) 548 (16.2) 240 (14.2) 0.002
Cataract 1572 (9.31) 642 (19.0) 323 (19.1) <0.0001
Diabetic retinopathy 242 (1.43) 112 (3.32) 39 (2.31) <0.0001
Liver cirrhosis 2697 (16.0) 2448 (72.5) 1537 (91.1) <0.0001
Obesity 362 (2.14) 83 (2.46) 45 (2.67) 0.24
Anemia 1388 (8.22) 595 (17.6) 249 (14.8) <0.0001
Medications
Statin 1182 (7.00) 212 (6.28) 73 (4.32) <0.0001
Aspirin 18 (0.11) 8 (0.24) 2 (0.12) 0.15
Nonsteroidal anti-inflammatory drugs 51 (0.30) 14 (0.41) 10 (0.59) 0.11

Data are expressed as mean (standard deviation) or number (percentage).